StageZero Life Sciences Ltd.
SZLSF
$0.0021
-$0.025-92.25%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -197.51% | -197.51% |
| Total Depreciation and Amortization | -- | -- | -- | -46.39% | -46.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 270.77% | 270.77% |
| Change in Net Operating Assets | -- | -- | -- | 13.39% | 13.39% |
| Cash from Operations | -- | -- | -- | 85.63% | 85.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 139.35% | 139.35% |
| Total Debt Repaid | -- | -- | -- | -62.66% | -62.66% |
| Issuance of Common Stock | -- | -- | -- | -87.30% | -87.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | 200.00% |
| Cash from Financing | -- | -- | -- | -80.26% | -80.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 99.37% | 99.37% |
